CMC 001

Drug Profile

CMC 001

Alternative Names: CMC-001

Latest Information Update: 09 Feb 2016

Price : $50

At a glance

  • Originator CMC Contrast
  • Class Contrast media; Heavy metals
  • Mechanism of Action Magnetic resonance imaging enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Liver disorders
  • New Molecular Entity No

Highest Development Phases

  • No development reported Liver disorders

Most Recent Events

  • 09 Feb 2016 No development reported - Phase-II for Liver disorders (Diagnosis) in USA (PO)
  • 27 Nov 2013 Phase-II clinical trials in Diagnostic imaging in USA (PO)
  • 27 Nov 2013 No development reported - Phase-III for Liver disorders in Sweden (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top